September 30, 2016, the sales volume and sales revenue increase while the sales unit decrease from the Third Quarter Ended September 30, 2016. That effected higher cost of goods sold from the fixed cost for
, showing a decrease of Baht 55.30 million or representing 24.14 % decrease since there have been only 5 ongoing projects whereas a subsidiary had 1 additional ongoing project with its contract value of Baht
849.62 Increase(Decrease) (2.39) 65.91 4.62 74.26 142.40 Compared revenue for 6 months (Million Baht) 3 of 8 Operating results classified by business are as follows: Management service business Revenue
, financial cost decreased by Baht 60 Million from principle repayment and refinancing long term loan of SOE in the end of the first quarter of this year resulting to the decrease in financial cost
Increase (Decrease) % Change Sales income 15,400.82 15,097.66 303.16 2.01% Rental and service income 493.36 480.81 12.55 2.61% Other income 599.77 577.93 21.84 3.78% Total revenues 16,493.95 16,156.40 337.56
necessary items, decrease in spending frequency and low-price favorable from consumer and retailer must also rely on promotion and marketing campaign. (Source : 3Q18 BOT Economic Report/EIC Outlook quarter 4
year, mostly from revenue from UAC which increased Baht 977.69 million, which resulted in the increase in gross profit of Baht 20.62 million and the decrease in gross profit margin for 9-month period of
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
and its subsidiary for the third quarter ended September 30, 2019 which the details are as follows: Unit: million Baht For 3-month period (July-Sep) 2019 2018 Change % Increase (Decrease) Revenue from
in Q1-2023. Total operating expenses in Q2-2023 have changed in the same direction and at a similar rate with the increase and decrease in revenue when compared to Q1- 2023 and Q2- 2022. However, the